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TAVI
ComplicationsAn 83-year-old high-risk gentleman diagnosedwith severe symptomatic aortic stenosis was scheduled for TAVR.
A 31mmCoreValve was implanted but severe paravalvular leakwas noted. A valve-in-valve procedure was per-
formed. However, the valve frame was partially dislodged into de ascending aorta. We report our strategy to
solve this severe leak after a failed valve-in-valve procedure.
© 2015 The Authors. Published by Elsevier Ireland Ltd.This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).An 83-year-old high-risk gentleman diagnosed with severe
symptomatic aortic stenosis was scheduled for TAVR. A CT scan
showed severe bulky calciﬁcation of aortic leaﬂets, mainly in the
non-coronary sinus. Annulus measurements were compatible with
a 31 mm CoreValve™ (Medtronic, Minneapolis, Minnesota). Afterisk) where de valve frame is deforme
valvular regurgitation located in non-
mplejo Asistencial Universitario
7 237 683.
oureiro).
land Ltd.This is an open access article uthe full release of the valve, we observed that the frame had popped
out and it was partially located above the leaﬂets (Fig. 1A). Severe
paravalvular regurgitation (PVR) was noted (Fig. 1B and C). The de-
cision was to proceed with a new 31 mm CoreValve, valve-in-valve
technique. The second valve was deployed in a deeper positiond. (B) Partial dislodgement of the TAV (arrow) and presence of severe aortic regurgitation
coronary sinus and occupying almost 50% of the circumference.
nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 2. (A) Second TAV implanted below the previous one.We can observe that the lower part is below the calcium landmark (arrow), but the valve frame is not fully expanded. (B) Balloon
postdilatation trying to fully expand the valve frame. (C)After postdilatation, the valve slipped again in the severe calciﬁcation andwas againpartially dislodged (arrow) leading to a severe
regurgitation (double arrow). (D) Severe PVL by TEE monitoring.
59R. Estévez-Loureiro et al. / IJC Heart & Vasculature 7 (2015) 58–60(6–8 mm) to ensure full coverage of the leak. The deployment was
correct, however still severe PVRwas noted (Fig. 2A).We decide to per-
form a balloon postdilatation with a NuCLEUS™ (NuMED Inc.) 28 mm
balloon to improve the expansion of the valve structure. Interestingly,
after the inﬂation, we realized that again the valve frame had slipped
in the bulky calciﬁcation and the valve was partially dislodged
(Fig. 2B, C and D). After considering different alternatives to solve theFig. 3. (A) Implant of third TAV far below the previous ones (arrow). (B) Only traces of aortic r
demonstrating the three valves in place (asterisk, arrow and double arrow). (D) A 3D CT scan
coronary arteries.PVR after a valve-in-valve procedure, we ﬁnally decided to implant a
third valve. Subsequently, we deployed a 29 mm CoreValve deep in
the left ventricular outﬂow tract (8–10 mm), and after complete
release, a new angiogram and TEE monitoring showed complete disap-
pearance of the PVR (Fig. 3A and B). A CT scan at 1-year follow-up
showed the position of valve frames and the patency of both coronary
arteries (Fig. 3C and D).egurgitation were seen in TEE imaging. (C) CT scan performed 1 year after the procedure
rendering reconstruction with the three valves and demonstrating the patency of both
60 R. Estévez-Loureiro et al. / IJC Heart & Vasculature 7 (2015) 58–60PVR is a major concern after TAVI since it is linked with an impaired
prognosis [1]. When severe PVR is noted during the procedure usually
balloon postdilatation or valve-in-valve procedures are the default
treatment strategies[2]. However, the solution of a PVR after a valve-
in-valve is challenging. This case is, to the best of our knowledge, the
ﬁrst to report a double valve-in-valve technique. We proved that a
third valve implantation is feasible and may solve the complication,
leading to persistent optimal results at one year of follow-up.
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